GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » AfterNext HealthTech Acquisition Corp (NYSE:AFTR) » Definitions » Net Current Asset Value

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Net Current Asset Value : $-0.38 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is AfterNext HealthTech Acquisition Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

AfterNext HealthTech Acquisition's net current asset value per share for the quarter that ended in Jun. 2023 was $-0.38.

The historical rank and industry rank for AfterNext HealthTech Acquisition's Net Current Asset Value or its related term are showing as below:

AFTR's Price-to-Net-Current-Asset-Value is not ranked *
in the Diversified Financial Services industry.
Industry Median: 1.75
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

AfterNext HealthTech Acquisition Net Current Asset Value Historical Data

The historical data trend for AfterNext HealthTech Acquisition's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AfterNext HealthTech Acquisition Net Current Asset Value Chart

AfterNext HealthTech Acquisition Annual Data
Trend Dec21 Dec22
Net Current Asset Value
-0.56 -0.35

AfterNext HealthTech Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only -0.37 -0.37 -0.35 -0.40 -0.38

Competitive Comparison of AfterNext HealthTech Acquisition's Net Current Asset Value

For the Shell Companies subindustry, AfterNext HealthTech Acquisition's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AfterNext HealthTech Acquisition's Price-to-Net-Current-Asset-Value Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, AfterNext HealthTech Acquisition's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where AfterNext HealthTech Acquisition's Price-to-Net-Current-Asset-Value falls into.



AfterNext HealthTech Acquisition Net Current Asset Value Calculation

AfterNext HealthTech Acquisition's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2022 is calculated as

Net Current Asset Value Per Share(A: Dec. 2022 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.989-11.945-0-0)/31.25
=-0.35

AfterNext HealthTech Acquisition's Net Current Asset Value (NCAV) per share for the quarter that ended in Jun. 2023 is calculated as

Net Current Asset Value Per Share(Q: Jun. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.147-11.956-0-0)/31.25
=-0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AfterNext HealthTech Acquisition  (NYSE:AFTR) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


AfterNext HealthTech Acquisition Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of AfterNext HealthTech Acquisition's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
301 Commerce Street, Suite 3300, City Fort Worth, TX, USA, 76102
Website
AfterNext HealthTech Acquisition Corp is a blank check company.
Executives
Jon Winkelried director, 10 percent owner C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Tpg Gp A, Llc director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
R Halsey Wise director, officer: Chief Executive Officer 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Julie L. Gerberding director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Bonderman director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
James G Coulter director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Tpg Group Holdings (sbs) Advisors, Inc. director, 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Jeffrey K. Rhodes director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Christopher H. Hunter director 500 W MAIN STREET, LOUISVILLE KY 40202
Bharat Sundaram director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Martin Davidson officer: Chief Financial Officer C/O TPG PACE ENERGY HOLDINGS CORP., 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Nehal Raj director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Anthony Jr Colaluca director, officer: President MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
William Joseph Miller director 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Agneta G. Breitenstein director C/OAFTERNEXT HEALTHTECH ACQUISITION CORP, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Headlines